Tristel plc (LON:TSTL - Get Free Report) passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 437.83 ($5.56) and traded as low as GBX 430 ($5.46). Tristel shares last traded at GBX 438 ($5.56), with a volume of 56,263 shares traded.
Tristel Price Performance
The company has a market cap of £208.47 million, a price-to-earnings ratio of 3,359.23 and a beta of 0.23. The company has a debt-to-equity ratio of 19.12, a quick ratio of 3.83 and a current ratio of 4.92. The company has a 50-day simple moving average of GBX 403.16 and a 200-day simple moving average of GBX 437.83.
Tristel Increases Dividend
The company also recently declared a dividend, which will be paid on Friday, December 20th. Investors of record on Thursday, November 28th will be issued a GBX 8.28 ($0.11) dividend. The ex-dividend date of this dividend is Thursday, November 28th. This represents a dividend yield of 2.1%. This is a boost from Tristel's previous dividend of $5.24. Tristel's dividend payout ratio is currently 10,000.00%.
Insider Buying and Selling
In related news, insider Elizabeth Dixon sold 50,000 shares of the company's stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of GBX 397 ($5.04), for a total value of £198,500 ($251,903.55). Insiders own 4.89% of the company's stock.
About Tristel
(
Get Free Report)
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Recommended Stories
Before you consider Tristel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.
While Tristel currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
